Given the enhanced antifibrotic efficacy observed when pirfenidone was combined with esomeprazole in vitro, we evaluated the efficacy of the combination in vivo in a mouse model of TGFβ-induced lung fibrosis. Here, TGFB1 is linked to pulmonary fibrosis.